On-Demand - Advances in the Treatment of Tics
Program Release: June 24, 2021
Expiration Date: June 24, 2023
*Recording of a live webinar originally held on 6/10/21
Estimated time to complete: 60 Minutes
There are no prerequisites for participation.
Dr. Joseph Jankovic
Professor of Neurology
Distinguished Chair in Movement Disorders Director, Parkinson’s Disease Center and Movement Disorders Clinic Director
Center of Excellence for Parkinson’s Foundation and Tourette Association of America
Baylor College of Medicine
Dr. Jankovic is a Professor of Neurology, Distinguished Chair in Movement Disorders, and Founder and Director of the Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC), Department of Neurology, Baylor College of Medicine, Houston, Texas. After completing his Neurology training at Columbia University, New York City, he joined the faculty of Baylor College of Medicine in 1977. Since that time he has led clinical team that focuses on the most compassionate and expert care and research on etiology, pathophysiology, and experimental therapeutics of Parkinson’s disease and related neurodegenerative and movement disorders such as tremors, dystonia, Tourette syndrome, Huntington disease, restless legs syndrome, tardive dyskinesia, and paroxysmal dyskinesias. Under the direction of Dr. Jankovic the PDCMDC has been recognized as “Center of Excellence” by the Parkinson’s Foundation, the Huntington Disease Society of America, the Tourette Association of America, and the Wilson Disease Association.
Past president of the International Parkinson and Movement Disorder Society and of the International Neurotoxin Association, Dr. Jankovic is the recipient of many awards including the American Academy of Neurology (AAN) Movement Disorders Research Award, First National Parkinson Foundation Distinguished Service Award, Huntington’s Disease Society of America Guthrie Family Humanitarian Award, Tourette Syndrome Association Lifetime Achievement Award, Dystonia Medical Research Foundation Distinguished Service Award, Benign Essential Blepharospasm Research Foundation Award, and Lifetime Achievement Award from the International Neurotoxin Association, Dr. Jankovic has been recognized as an Honorary Member of the American Neurological Association, Australian Association of Neurologists, French Neurological Society, and the International Parkinson’s Disease and Movement Disorders Society.
Motor and phonic tics associated with Tourette syndrome (TS) can range in severity from barely perceptible to disabling and most patients have a variety of behavioral co-morbidities, particularly, attention deficit disorder and obsessive-compulsive disorder. Therefore, therapy must be tailored to the individual needs of the patients. In addition to behavioral therapy, oral medications such as alpha agonists, dopamine depletors, anti-psychotics, and topiramate are used to control the involuntary movements and noises. Botulinum toxin injections are particularly effective in patients with troublesome focal motor and phonic tics, including coprolalia. Deep brain stimulation may be considered for patients with “malignant” TS, that is, refractory to medical therapy. When appropriate therapy is selected and implemented, most patients with TS can achieve their full potential and lead essentially normal life.
Physicians and Physician Specialists, Physician Assistants, Nurse Practitioners, Registered Nurses, Psychologists, Social Workers, Medical Students, Residents, Fellows and other allied healthcare professionals engaged in the care of patients with Tourette syndrome.
After participating in this webinar, participants should be better able to:
- Review the current therapeutic approach in patients with tics and Tourette syndrome.
- State the rationale for and basic pharmacology of novel drugs used in the treatment of Tourette syndrome.
- Identify emerging medical and surgical treatments of tics.
METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT
There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives, faculty information, and CME information prior to participating in the activity.
- View the CME presentations
- Complete the CME activity evaluation at the conclusion of the activity in order to receive a credit certificate.
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.
Faculty Disclosure/Conflict of Interest
The following speakers and planning committee members* have disclosed the following financial relationships:
Joseph Jankovic, MD receives grant/research support and consulting fees from Teva
Jennifer Maloney* has nothing to disclose
Angela Sullivan, MPH* has nothing to disclose
Maria Sullivan, BS* has nothing to disclose
Chelsea Tollner* has nothing to disclose
Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.
Physicians: The Warren Alpert Medical School of Brown University designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants & Nurse Practitioners: Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hours AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
- 1.00 AMA PRA Category 1 Credit™The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 1.00 AttendanceParticipants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.